Back to all studies
RecruitingNCT04373317

CSP #2015 - Comparator Study of Antipsychotics Pimavanserin and Quetiapine for Parkinson''s Disease Psychosis (C-SAPP)

The registry lists this study as recruiting. Study locations are listed in the United States. Confirm recruitment at each site. It is testing antipsychotics Pimavanserin and Quetiapine for Parkinson's Disease Psychosis.

SchizophreniaDrugOver 40 Years
In plain English

Key information made simple

What is this study testing?

This study is testing whether Antipsychotics Pimavanserin and Quetiapine may be useful for adults experiencing schizophrenia.

What would participation involve?

Participants may receive Antipsychotics Pimavanserin and Quetiapine, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: October 24, 2022
Recruitment status
Recruiting
Enrollment listed in the registry
358
Sponsor
VA Office of Research and Development
Sponsor type
Government agency
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
Over 40 Years
Official registry ID
NCT04373317
Official title
CSP #2015 - Multicenter, Randomized, Double-blind Comparator Study of Antipsychotics Pimavanserin and Quetiapine for Parkinson''s Disease Psychosis (C-SAPP)

Want help reviewing this study?

Loading the security check...
Study ID: NCT04373317. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 24 sites
  • Southern Arizona VA Health Care System, Tucson, AZ
    Tucson, Arizona
    Site status: Terminated
  • VA Loma Linda Healthcare System, Loma Linda, CA
    Loma Linda, California
    Site status: Recruiting
  • VA Palo Alto Health Care System, Palo Alto, CA
    Palo Alto, California
    Site status: Recruiting
  • San Francisco VA Medical Center, San Francisco, CA
    San Francisco, California
    Site status: Terminated
  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA
    West Los Angeles, California
    Site status: Terminated
  • Rocky Mountain Regional VA Medical Center, Aurora, CO
    Aurora, Colorado
    Site status: Recruiting
  • North Florida/South Georgia Veterans Health System, Gainesville, FL
    Gainesville, Florida
    Site status: Terminated
  • Edward Hines Jr. VA Hospital, Hines, IL
    Hines, Illinois
    Site status: Terminated
  • Lexington VA Medical Center, Lexington, KY
    Lexington, Kentucky
    Site status: Terminated
  • VA Ann Arbor Healthcare System, Ann Arbor, MI
    Ann Arbor, Michigan
    Site status: Terminated
  • Minneapolis VA Health Care System, Minneapolis, MN
    Minneapolis, Minnesota
    Site status: Recruiting
  • St. Louis VA Medical Center John Cochran Division, St. Louis, MO
    St Louis, Missouri
    Site status: Terminated
  • New Mexico VA Health Care System, Albuquerque, NM
    Albuquerque, New Mexico
    Site status: Terminated
  • Syracuse VA Medical Center, Syracuse, NY
    Syracuse, New York
    Site status: Terminated
  • Asheville VA Medical Center, Asheville, NC
    Asheville, North Carolina
    Site status: Terminated
  • Louis Stokes VA Medical Center, Cleveland, OH
    Cleveland, Ohio
    Site status: Recruiting
  • VA Portland Health Care System, Portland, OR
    Portland, Oregon
    Site status: Recruiting
  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
    Philadelphia, Pennsylvania
    Site status: Recruiting
  • Philadelphia MultiService Center, Philadelphia, PA
    Philadelphia, Pennsylvania
    Site status: Recruiting
  • Tennessee Valley Healthcare System Nashville Campus, Nashville, TN
    Nashville, Tennessee
    Site status: Terminated
  • Michael E. DeBakey VA Medical Center, Houston, TX
    Houston, Texas
    Site status: Recruiting
  • South Texas Health Care System, San Antonio, TX
    San Antonio, Texas
    Site status: Terminated
  • Hunter Holmes McGuire VA Medical Center, Richmond, VA
    Richmond, Virginia
    Site status: Terminated
  • VA Puget Sound Health Care System Seattle Division, Seattle, WA
    Seattle, Washington
    Site status: Terminated
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Pimavanserin, Quetiapine. Phase 4 studies usually happen after treatment approval, to monitor real-world use.

Who might this study be for?

This study may concern people with schizophrenia; age range: Over 40 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by VA Office of Research and Development, which appears to be a government agency. Sponsor website: https://www.research.va.gov. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as recruiting. Individual sites may have different statuses. The research team must confirm whether a site is open and whether you meet the criteria.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me